DistantNews
Support us
๐Ÿ‡จ๐Ÿ‡ฑ Chile /Health & Science

Chile announces all cancer types to be included in GES by 2028

From BioBioChile · () Spanish

Translated from Spanish, summarized and contextualized by DistantNews.

At a glance

News Sources not specified New plan
  • Chile's Ministry of Health announced that all types of cancer will be included in the GES (Guaranteed Explicit Health Services) plan starting in 2028.
  • This expansion aims to ensure broader access to cancer treatments for the population.
  • The announcement signifies a significant policy change in the country's healthcare system.

Chile's Ministry of Health has announced a significant expansion of its public health system, confirming that all types of cancer will be incorporated into the GES (Guaranteed Explicit Health Services) plan by 2028. This move is expected to dramatically improve access to diagnosis, treatment, and follow-up care for cancer patients across the country.

The GES framework guarantees a set of specific health services for various conditions, ensuring timely access and comprehensive coverage. The inclusion of all cancers represents a major commitment by the government to combat the disease and alleviate the financial burden on patients and their families.

This policy change is anticipated to streamline the healthcare process for cancer patients, reducing waiting times and ensuring that essential treatments are available regardless of a patient's socioeconomic status. The government aims to provide a more equitable and effective response to cancer care nationwide.

Further details regarding the implementation and specific services covered under the expanded GES plan are expected to be released as the 2028 deadline approaches. The announcement marks a pivotal step in strengthening Chile's healthcare infrastructure and its approach to managing oncological diseases.

DistantNews Editorial

Originally published by BioBioChile in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.